Content area

|
|

Behandlingsniveau og behandlingsstop ved benign lungesygdom

Det er vigtigt, at læger og plejepersonale afholder samtaler med patient og pårørende om livet med svær sygdom, herunder afklarende samtaler om behandlingsniveau.
Forfatter(e)
Anita Rath Sørensen1, Elisabeth Bendstrup1, Anders Løkke1, Ingrid Louise Titlestad2, Jens Ulrik Stæhr Jensen3, Laura Hohwu Thomsen4,
Nassim Bazeghi Roberts5, Pia Holland Gjørup6, Saher Shaker3, Svend Gundestrup5, Torgny Rostrup Wilcke3, Ulla Møller Weinreich7, Kristoffer Marså8. 1. Lungemedicinsk Afdeling B, Aarhus Universitetshospital2. Lungemedicinsk Afdeling, Odense Universitetshospital3. Lungemedicinsk Afdeling, Herlev-Gentofte Hospital4. Lungemedicinsk Afdeling, Hvidovre Amager Hospital5. Lungemedicinsk Afdeling, Bispebjerg og Frederiksberg Hospital6. Onkologisk Afdeling, Herning Sygehus7. Lungemedicinsk Afdeling, Aalborg Universitetshospital8. Palliationsenheden, Herlev og Gentofte Hospital

Ugeskr Læger 2018;180:V04180270
Reference: 
Ugeskr Læger 2018;180:V04180270
Sidetal: 

Anita Rath Sørensen, Elisabeth Bendstrup, Anders Løkke, Ingrid Louise Titlestad, Jens Ulrik Stæhr Jensen, Laura Hohwu Thomsen, Nassim Bazeghi Roberts, Pia Holland Gjørup, Saher Shaker, Svend Gundestrup, Torgny Rostrup Wilcke, Ulla Møller Weinreich, Kristoffer Marså:

Treatment limitations or discontinuation in patients with benign pulmonary diseases

Ugeskr Læger 2018;180:V04180270

The decision to limit or discontinue treatment is a difficult issue, which all physicians will face. Timely communication with information on treatment possibilities and limitations, respectful listening to patients‘ and informal caregivers‘ wishes and early palliation is recommended in a stable phase. In some situations, it is better to stop life-prolonging treatment and optimise quality of life in patients with benign pulmonary diseases. Decision on treatment limitations or discontinuation is best taken at a conference and should be based on the patient’s wishes, the disease stage and progression and potential reversible components.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Per E. Holstein | 17/12
7 kommentarer
af Elo Aagaard Rasmussen | 17/12
19 kommentarer
af Hanne Hermann | 17/12
1 Kommentar
af Mette Holland-Fischer | 17/12
1 Kommentar
af Erik Sloth | 17/12
8 kommentarer
af Frank Thor Jørgensen | 16/12
2 kommentarer
af Trine Cecilie Jeppesen | 15/12
1 Kommentar
af Lars Linnet | 14/12
1 Kommentar